Legal Representation
Attorney
Chris P. Cheng
USPTO Deadlines
Next Deadline
1292 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20230808)
Due Date
August 08, 2029
Grace Period Ends
February 08, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 9, 2025 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Jul 9, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jul 9, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jul 9, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Aug 8, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Aug 8, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| May 23, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 23, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 3, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 18, 2023 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 18, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Apr 18, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 18, 2023 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 18, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Oct 4, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 4, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Oct 4, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 26, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 29, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 25, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical and biological preparations for immunotherapy, including cell therapy and gene therapy; pharmaceutical and biological preparations for medical diagnostic use; pharmaceutical and biological preparations for medical use, namely, for the prevention and treatment of diseases and disorders of the nervous system, the immune system and the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system, and for the treatment of inflammatory diseases and disorders; pharmaceutical and biological preparations for medical use, namely, for use in dermatology, oncology, hematology and in tissue and organ transplantation in ophthalmology and for gastroenterological diseases and disorders
First Use Anywhere:
Jun 22, 2021
First Use in Commerce:
Jun 22, 2021
Classification
International Classes
005